JPS6253981A - Novel benzoic acid derivative - Google Patents

Novel benzoic acid derivative

Info

Publication number
JPS6253981A
JPS6253981A JP19337885A JP19337885A JPS6253981A JP S6253981 A JPS6253981 A JP S6253981A JP 19337885 A JP19337885 A JP 19337885A JP 19337885 A JP19337885 A JP 19337885A JP S6253981 A JPS6253981 A JP S6253981A
Authority
JP
Japan
Prior art keywords
group
formula
acid
derivative
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP19337885A
Other languages
Japanese (ja)
Inventor
Koichi Shiyudo
紘一 首藤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP19337885A priority Critical patent/JPS6253981A/en
Publication of JPS6253981A publication Critical patent/JPS6253981A/en
Pending legal-status Critical Current

Links

Landscapes

  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Quinoline Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

NEW MATERIAL:A benzoic acid derivative shown by the formula I[R is alkyl; R1 is halogen; R2 is H, methyl or ethyl; X is O, S, =SO2, =SO, =NH, =N-CH3 or =N<+>(CH3)2; Y is -CONR3-, -NR3CO-, -COCR3=CR3-, -CR3=CR3CO-, -N=N-, -N=N(O)-, -N(O)=N- or group shown by the formula II (R3 is H, methyl or ethyl)]. EXAMPLE:Terephthalic acid(4,4-dimethylchromanyl)amidomethyl ester. USE:A remedy for diseases such as cartilaginous disease, dermatosis such as psoriasis, malignant disease such as leukemina, etc., caused by stagnation or abnormality of differentiation. PREPARATION:For example, a corresponding acetophenone is condensed with a terephthalaldehydric acid ester or its derivative in the presence of a base to give a compound shown by the formula I wherein Y is -CO-CR3=CH- group.

Description

【発明の詳細な説明】 発明の目的: 軟骨変性疾患、乾せんのような皮膚科疾患及び白血病の
ような悪性疾患は分化の停滞または異常を原因とする疾
患とみなされている。
DETAILED DESCRIPTION OF THE INVENTION Object of the Invention: Cartilage degenerative diseases, dermatological diseases such as psoriasis, and malignant diseases such as leukemia are considered to be diseases caused by stagnant or abnormal differentiation.

この発明は、人や動物のそれら疾患の治療を可能ならし
める、医薬として価値ある新規有機化合物を提供するも
のである。
This invention provides novel organic compounds of pharmaceutical value that enable the treatment of these diseases in humans and animals.

従来の技術: 癌細胞の分化を促し説癌させる、という興味深い方法が
存在することは、既に知られている。
BACKGROUND OF THE INVENTION It is already known that there are interesting methods for promoting the differentiation of cancer cells and causing them to develop cancer.

(a)J、Med、Chem、25 1289  (1
982)、 (b)CancerResearch(S
upple、)4!12469s−2475s (c)
 BLOOD ofJ、A、S、of  Hemato
logy  64 709−721(1983) (d
)Experientla 34 1105−1246
 (e)細胞工学 2゜No、12 (1983)− これら文献は、またレチノイドおよびその関連化合物が
腫瘍や外皮層材領域における治療に特徴的な効果を示す
ことを報告している。
(a) J, Med, Chem, 25 1289 (1
982), (b) Cancer Research (S
apple,)4!12469s-2475s (c)
BLOOD of J, A, S, of Hemato
logy 64 709-721 (1983) (d
)Experientla 34 1105-1246
(e) Cell Engineering 2° No. 12 (1983) - These documents also report that retinoids and their related compounds exhibit characteristic effects in the treatment of tumors and integumentary areas.

ドイツ公開公報 28 54 354には p−((E
)−2−(5,G、7.8−テトラヒドロ−9,5,8
,8−テトラメチル−2−ナフチル)ブaヘニル)安息
香酸が良性または悪性の腫瘍の全身治療および局所治療
並びに上記疾患の予防に使用でき、薬理学的に価値有る
何月な化合物であることが報告せられている。
In German Publication No. 28 54 354 p-((E
)-2-(5,G,7.8-tetrahydro-9,5,8
, 8-tetramethyl-2-naphthyl)buhenyl)benzoic acid is a pharmacologically valuable compound that can be used in the systemic and local treatment of benign or malignant tumors and in the prevention of the above-mentioned diseases. has been reported.

それら化合物はまた、にきび、かいぜん、その他の肥厚
するか又は病理的に変化した角化を伴う皮膚病やアレル
ギーや炎症性疾患の全身的又は局所的治療に適している
The compounds are also suitable for the systemic or local treatment of acne, pimples, other skin diseases involving thickened or pathologically altered keratosis, as well as allergic and inflammatory diseases.

また、7メリ6特許出願Ser、No、511037に
は上記化合物の同族体が関節疾患にかかった哺乳類に投
与することにより、軟骨の変性を阻止するという効果を
有することが報告されている。
In addition, it has been reported in 7 Meri 6 Patent Application Ser. No. 511037 that homologs of the above compounds have the effect of inhibiting cartilage degeneration when administered to mammals suffering from joint diseases.

発明の構成: 式中、Rは1ないし4個の炭素原子を有するアルキル基
、殊にメチル基またはエチル基、R□はハロゲン原子、
Rは水素原子、メチル基またはエチル基、Xは酸素原子
、硫黄原子、=S02、=基、モしてYは次式の基 −CONR− −NR3CO− いる。
Structure of the invention: In the formula, R is an alkyl group having 1 to 4 carbon atoms, in particular a methyl group or an ethyl group, R□ is a halogen atom,
R is a hydrogen atom, a methyl group or an ethyl group; X is an oxygen atom, a sulfur atom, a =S02, = group; and Y is a group of the following formula -CONR- -NR3CO-

本発明の一般式(I)で示される化合物は、以下のよう
にして製造できる。
The compound represented by the general formula (I) of the present invention can be produced as follows.

(a)下記一般式(I)の基Yが一〇〇−CR3=CH
−基を示す化合物を対応するアセトフェノン誘導体とテ
レフタルアルデヒド酸エステル又はその誘導体とを塩基
の存在下縮合させることにより、 合物を対応するY基が CR===CR基      を示す化合物をエポキシ
化剤を用いて酸化することにより(c)Yが−N = 
N−基である化合物は対応するア二IJンの誘導体を酸
触媒の存在又は非存在下でバラニトロソ安息香酸エステ
ルと縮合することにより (d)Yが−N(0)=N−基または−N=N (O)
−基である化合物は対応するフェニルヒドロキシアミン
とバラニトロソ安息香酸又はその誘導体とを(C)項に
おけると同様に縮合させることにより (e)Yが−N=N(0)−基または−N (0)=N
−基である化合物を対応するニトロソベンゼン誘導体と
バラヒドロキシアミノ安息香酸又はその誘導体と(C)
項におけると同様に縮合させことにより (f)Yが−NR−Go−基である化合物は対応するア
ニリン誘導体をテレフタール酸の反応性誘導体(酸ハロ
ゲニド又はエステル等)でアシル化することにより (g)Yが−Co−NR−である化合物はバラアミノ安
息香酸又はそのエステルを対応する安息6酸の反応性誘
導体(酸ハロゲニド又はエステル等)で常法によりアシ
ル化することにより製造し、その様にして得られた化合
物を所望により加水分解する。
(a) Group Y of the following general formula (I) 100-CR3=CH
By condensing a compound showing a - group with a corresponding acetophenone derivative and a terephthalaldehyde acid ester or its derivative in the presence of a base, a compound in which the corresponding Y group shows a CR===CR group can be converted into an epoxidizing agent. By oxidizing using (c) Y is -N =
Compounds that are N-groups can be prepared by condensing the corresponding derivative of anidine with varanitrosobenzoic acid ester in the presence or absence of an acid catalyst (d) where Y is an -N(0)=N- group or - N=N (O)
- group can be obtained by condensing the corresponding phenylhydroxyamine and varanitrosobenzoic acid or its derivatives in the same manner as in section (C). 0)=N
- group with the corresponding nitrosobenzene derivative and parahydroxyaminobenzoic acid or its derivative (C)
(f) Compounds in which Y is -NR-Go- group can be obtained by acylating the corresponding aniline derivative with a reactive derivative (acid halide or ester, etc.) of terephthalic acid (g ) Compounds in which Y is -Co-NR- are produced by acylating para-aminobenzoic acid or its ester with the corresponding reactive derivative of benzoic acid (acid halide or ester, etc.) by a conventional method; The compound obtained is hydrolyzed as desired.

以下、実施例により、本発明の化合物の製造方法を説明
するが、本発明の化合物はそれら製法に限定されるもの
ではなく、自体公知の方法によってその他の方法によっ
ても専門家に容易に製造できる。
Hereinafter, the method for producing the compound of the present invention will be explained with reference to Examples, but the compound of the present invention is not limited to these production methods, and can be easily produced by experts by methods known per se or other methods. .

実施例−1テレフ ル     −ジメチルクマンル 
ア々ド メチルエステル 6−アミノ−4,4−ジメチルクロマン 0゜177g
 (1mmol)をベンゼン10−1に溶かし、ピリジ
ン1m1(過剰)とテレフタル酸モノメチルエステルク
ロリド 0.2g (1,01m1Ilol)を順次加
え、室温下で3時間半撹拌する。反応液に水50m1を
加え、酢酸エチル75m1で3回抽出。
Example-1 Teleflu-dimethyl cumanlu
Arado Methyl Ester 6-Amino-4,4-dimethylchroman 0゜177g
(1 mmol) was dissolved in benzene 10-1, 1 ml (excess) of pyridine and 0.2 g (1,01 ml) of terephthalic acid monomethyl ester chloride were sequentially added, and the mixture was stirred at room temperature for 3.5 hours. Add 50 ml of water to the reaction solution, and extract 3 times with 75 ml of ethyl acetate.

抽出液を順次IN塩酸100層1、水100ニア、飽和
重炭酸ソーダ100Ill、水1001、飽和食塩水1
00m1で洗い、硫酸マグネシウムで乾燥後、溶媒を留
去して、淡黄色油状物0.352gを得た。これをベン
ゼン−ヘキサンから再結晶することにより、0.29g
の標記化合物を淡黄色針状晶として得ることができた。
The extract was sequentially mixed with 100 layers of hydrochloric acid, 100 layers of water, 100 layers of saturated sodium bicarbonate, 100 layers of water, and 1 layer of saturated saline.
After washing with 00 ml of water and drying with magnesium sulfate, the solvent was distilled off to obtain 0.352 g of a pale yellow oil. By recrystallizing this from benzene-hexane, 0.29 g
The title compound was obtained as pale yellow needles.

m、p、   129−130° C NMR(CDCI  )  δ1.35 (s、8)、
δ1.84 (t、2.J=5L δ3.95 (s。
m, p, 129-130°C NMR (CDCI) δ1.35 (s, 8),
δ1.84 (t, 2.J=5L δ3.95 (s.

3)、64.20 (t、2.J=5)、66.77 
(d、1.J=2)、67.89 (d、2.J=9)
、δ7. 92 (broads、  1) 、δ8.
11(d、2.J=9) IR3380cg+−1(N−H)、1715 (エス
テル)、IE375 (アミド)、815(p−)元素
分析値 計算値 C70,78%、H6,23%、 N 4.1
3%実測値 C70,64%、HG、28 %、  N
 4.01%同様にして原料として6−アミノ−4,4
−ジメチルクロマンの代わりに参考例 1によりえられ
た6−エチルアミノ−4,4−ジメチルクロマンを用い
て対応するアルキルアミド化合物を得た。
3), 64.20 (t, 2.J=5), 66.77
(d, 1.J=2), 67.89 (d, 2.J=9)
, δ7. 92 (broads, 1), δ8.
11 (d, 2.J=9) IR3380cg+-1 (NH), 1715 (ester), IE375 (amide), 815 (p-) Elemental analysis calculated value C70, 78%, H6, 23%, N 4.1
3% actual value C70, 64%, HG, 28%, N
4.01% Similarly, 6-amino-4,4 as a raw material
The corresponding alkylamide compound was obtained by using 6-ethylamino-4,4-dimethylchroman obtained in Reference Example 1 instead of -dimethylchroman.

4−ジメチルクロマン4.354gを無水酢酸8ni1
に溶かし、61%硝酸3. Ool (1,5等量)を
無水酢酸9mlに溶かしたものを0°Cで撹拌下、10
分間かけて滴五050分後飽和炭酸ソーダ水200II
llにあけ、ジクロルメタン400ニアで抽出。
4.354g of 4-dimethylchroman was added to 8ni1 of acetic anhydride.
Dissolve in 61% nitric acid 3. A solution of Ool (1.5 equivalents) in 9 ml of acetic anhydride was stirred at 0°C for 10 min.
Drops over 50 minutes After 50 minutes saturated soda water 200 II
Pour into 1 liter and extract with 400ml of dichloromethane.

水200m1で2回、飽和食塩水100組で1回洗い、
硫酸マグネシウムで乾燥、減圧上溶媒留去し、5.32
7gの褐色結晶を得た。カラムクロマトグラフィー(溶
出溶媒ジクロルエタン/n−ヘキサン2ニア)で分離に
より、4,4−ジメチル−6−二トロクロマンの淡黄色
結晶2.811g(4゜4−ジメチルクロマンからの収
率50.5%)、4.4−ジメチル−8−二トロクロマ
ンの赤色油状物2.004g (収率36.0%)、混
合物0゜312gを得た。4,4−ジメチル−θ−ニト
ロクロマンをヘキサンから再結晶し、2.581g(4
6,4%)淡黄色結晶を得た。
Wash twice with 200ml of water and once with 100 sets of saturated saline,
Dry over magnesium sulfate, remove solvent under reduced pressure, 5.32
7 g of brown crystals were obtained. Separation by column chromatography (eluent dichloroethane/n-hexane) yielded 2.811 g of pale yellow crystals of 4,4-dimethyl-6-nitrochroman (yield 50.5% from 4°4-dimethylchroman). ), 2.004 g (yield 36.0%) of a red oil of 4,4-dimethyl-8-nitrochroman, and 312 g of a mixture were obtained. 4,4-Dimethyl-θ-nitrochroman was recrystallized from hexane to yield 2.581 g (4
6.4%) pale yellow crystals were obtained.

こうして得られた 4,4−ジメチル−6−二トロクロ
マン 1..438gをエタノール120岨に溶かし、
Pd−炭素 0.75g(エタノール301)を加え、
2時間半水素接触還元する。Pd−炭素をろ去し、減圧
留去して褐色油状物1゜514gを得た。これをカラム
(ジクロルエタン/ヘキサン(2: 1) )で分離し
、6−アミノ−4,4−ジメチルクロマン 0.589
8g (4゜4−ジメチル−6−二トロクロマンからの
収率48.0%)、6−エチルアミノ−4,4−ジメチ
ルクロマン 0.25g (17,8%)、混合物0.
5850gを得た。
4,4-dimethyl-6-nitrochroman thus obtained 1. .. Dissolve 438g in 120ml of ethanol,
Add 0.75 g of Pd-carbon (ethanol 301),
Hydrogen catalytic reduction is carried out for 2 and a half hours. Pd-carbon was filtered off and evaporated under reduced pressure to obtain 1.514 g of a brown oil. This was separated using a column (dichloroethane/hexane (2:1)) and 6-amino-4,4-dimethylchroman 0.589
8 g (yield 48.0% from 4°4-dimethyl-6-nitrochroman), 0.25 g (17.8%) of 6-ethylamino-4,4-dimethylchroman, 0.25 g (17.8%) of mixture.
5850g was obtained.

6−アミノ−4,4−ジメチルクロマン淡褐色オイル NMR(CDCI  )  δ1.31 (s、 6)
、δ1.82 (t、 2.  J=El)、δ3.1
4(s。
6-amino-4,4-dimethylchroman light brown oil NMR (CDCI) δ1.31 (s, 6)
, δ1.82 (t, 2. J=El), δ3.1
4 (s.

2、NH2) 、δ4.0B (t、2.J=6)、δ
6.3−6. Et5 (m、 3)6−エチルアミノ
−4,4−ジメチルクロマン褐色油状物 NMR(CDCI  ’)  61.31 (t、 3
.  J=7)、δ1.35 (s、 6)、δ1.7
7 (t。
2, NH2), δ4.0B (t, 2.J=6), δ
6.3-6. Et5 (m, 3) 6-ethylamino-4,4-dimethylchroman brown oil NMR (CDCI') 61.31 (t, 3
.. J=7), δ1.35 (s, 6), δ1.7
7 (t.

2、J=5)、62.74 (s、1)、δ3.07 
(q、  2.  J=7Lδ4.04 (t、  2
.  J=5)、δ6.2−8.8 (m、 3)実[
−テレフ ル     −ジメチル実施例1で得たメチ
ルエステル0.188g(0、495mmol)を4.
5mlのメタノールに溶かし、1.85N苛性カリ0.
 4ml (74mmol)を滴下、次いで水2mlを
加え、16時間撹拌(室温下)、IN塩酸で中和し、酢
酸エチル(50slで2回)で抽出。これを水150w
11飽和塩化力ルシウム100m1で洗い、硫酸ソーダ
で乾燥後、減圧留去。テレフタル酸(N−4,4−ジメ
チル−6−クロマニル)アミドの淡黄色結晶0.180
g(メチルエステルからの収率99.3%)を得た。う
ち148mgを酢酸エチル−ヘキサンより再結晶し、淡
黄色結晶94mgを得た(収率 58゜3%)。
2, J=5), 62.74 (s, 1), δ3.07
(q, 2. J=7Lδ4.04 (t, 2
.. J=5), δ6.2-8.8 (m, 3) real [
-Terefluor-dimethyl 0.188 g (0.495 mmol) of the methyl ester obtained in Example 1 was added to 4.
Dissolved in 5 ml of methanol and added 1.85N caustic potassium 0.
4 ml (74 mmol) was added dropwise, then 2 ml of water was added, stirred for 16 hours (at room temperature), neutralized with IN hydrochloric acid, and extracted with ethyl acetate (2 x 50 sl). Add this to 150w of water
11 Wash with 100 ml of saturated lucium chloride, dry with sodium sulfate, and evaporate under reduced pressure. Pale yellow crystals of terephthalic acid (N-4,4-dimethyl-6-chromanyl)amide 0.180
g (99.3% yield from methyl ester) was obtained. Of this, 148 mg was recrystallized from ethyl acetate-hexane to obtain 94 mg of pale yellow crystals (yield: 58.3%).

m、p、  230.5−231.5° CNMRδ1
.35 (s、  8)、δ1.84 (tt2、J=
5)、64. 17 (t、 2.  J=5)、δ5
.2 (broad Sr  1) 、δ6.73 (
d、  1゜J=9Lδ7.38 (dd、1.J=9
.J=3)、δ7.69 (d、1.J=3)、δ7.
97 (d、  2.  J=9)、δ8. 11 (
d、  2.  J=9)、69.32 (s、1) IR3320cm+−1,3000(broad)、1
72011675.820 元素分析値 C工、H1gNO4 計算値 C70,14%、H5,89%、N 4.31
%実測値 C[i9.82%、  C5,92%、  
C4,QEi%エステル 参考例2で合成した6−アミノ−4,4−ジメチルチオ
クロマン200mg(1,036+mol)とテレフタ
ル酸クロライドモノメチルエステル205mg(1,0
36mmol)とを、101の無水ベンゼン中ピリジン
1mlを加え、室温で撹拌しながら1時間半反応させる
。反応液に水を加え酢酸エチルで抽出。有機層を0.2
N硝酸鋼の水溶液で青色がなくなるまで洗い、水、飽和
重炭酸水、水、飽和食塩水で順次洗う。硫酸マグネシウ
ムで脱水して溶媒留去し、317mgの標記化合物を淡
黄色結晶として得た(86.2%)。メタノールより再
結晶して淡黄色針状晶248mg(67,4%)を得た
。ベンゼンより再々結晶して無色の針状晶を得た。
m, p, 230.5-231.5° CNMRδ1
.. 35 (s, 8), δ1.84 (tt2, J=
5), 64. 17 (t, 2. J=5), δ5
.. 2 (broad Sr 1), δ6.73 (
d, 1°J=9Lδ7.38 (dd, 1.J=9
.. J=3), δ7.69 (d, 1.J=3), δ7.
97 (d, 2. J=9), δ8. 11 (
d, 2. J=9), 69.32 (s, 1) IR3320cm+-1,3000(broad), 1
72011675.820 Elemental analysis value C, H1gNO4 Calculated value C70, 14%, H5, 89%, N 4.31
% actual value C[i9.82%, C5,92%,
C4,QEi% Ester 200 mg (1,036 + mol) of 6-amino-4,4-dimethylthiochroman synthesized in Reference Example 2 and 205 mg (1,0 mol) of terephthalic acid chloride monomethyl ester.
36 mmol) was added with 1 ml of 101 pyridine in anhydrous benzene, and reacted at room temperature for 1.5 hours with stirring. Add water to the reaction solution and extract with ethyl acetate. 0.2 organic layer
Wash with an aqueous solution of N nitric acid steel until the blue color disappears, and then sequentially with water, saturated bicarbonate water, water, and saturated saline. After dehydration over magnesium sulfate and evaporation of the solvent, 317 mg of the title compound was obtained as pale yellow crystals (86.2%). Recrystallization from methanol gave 248 mg (67.4%) of pale yellow needle crystals. It was crystallized again from benzene to obtain colorless needle crystals.

m、1)、185〜187° C 元素分析値 C2゜H2□N03S 計算値 CC7,59%、  C5,9G%、  N3
.94%実測値 CC7,55%、  85.98%、
N3.67%NMR(60MHz  CDCl  )δ
1.29s (6H)、δ1.8E3m(2H)、δ3
.00s (2H)、δ3.90s (3H)、δ6.
97d (IH,J=8.5Hz)、δ7゜29dd 
(IH,J”8.5Hz、J=2Hz)、δ7.89d
 (IH,J=2Hz)、67.81d (IH,J=
8.5Hz)、δ8.01d(IH,J=8.5Hz)
、δ8.08s (IH)IR(KBr)16EtO(
アミド)、1691.1279  c++−’ 参考■−2−−ジメチル−−アロノー 3gの4,4−ジメチル−6−アセチルチオクロマン(
13,6ff1mol) 、H2NOH@HC11゜4
1 g (20,4mmol)を30m1のエタノール
に溶かし、これにピリジン61を加えて5分還流させた
。溶媒を留去し、200m1のジクロルメタンに溶かし
て水(80sl)塩酸(2N、80+alX2)食塩水
(80sl)で洗って、硫酸ソーダで脱水。
m, 1), 185-187° C Elemental analysis value C2°H2□N03S Calculated value CC7,59%, C5,9G%, N3
.. 94% actual value CC7, 55%, 85.98%,
N3.67% NMR (60MHz CDCl) δ
1.29s (6H), δ1.8E3m (2H), δ3
.. 00s (2H), δ3.90s (3H), δ6.
97d (IH, J=8.5Hz), δ7゜29dd
(IH, J”8.5Hz, J=2Hz), δ7.89d
(IH, J=2Hz), 67.81d (IH, J=
8.5Hz), δ8.01d (IH, J=8.5Hz)
, δ8.08s (IH)IR(KBr)16EtO(
amide), 1691.1279 c++-' Reference ■-2-dimethyl--3 g of 4,4-dimethyl-6-acetylthiochroman (
13,6ff1mol), H2NOH@HC11゜4
1 g (20.4 mmol) was dissolved in 30 ml of ethanol, pyridine 61 was added thereto, and the mixture was refluxed for 5 minutes. The solvent was distilled off, the solution was dissolved in 200 ml of dichloromethane, washed with water (80 sl), hydrochloric acid (2N, 80+alX2) and brine (80 sl), and dehydrated with sodium sulfate.

溶媒を留去して淡黄色結晶を3.08g (96゜4%
)得た。これをベンゼン/ヘキサンよす再結晶して無色
針状晶2.786gを得た(87.2%)。
The solvent was distilled off to obtain 3.08g of pale yellow crystals (96°4%
)Obtained. This was recrystallized in benzene/hexane to obtain 2.786 g of colorless needle crystals (87.2%).

m、 p、108〜109°C 元素分析値 C工、Hl、7NO8 計算値 CC8,27%、  87.28%、C5,9
5%実測値 C68,27%、87.38%、N 5.
73%上記のオキシム2.330g (9,915mm
ol)を70m1の乾燥エーテルに溶かし、これを水食
塩水で一10° Cに冷やす。これを攪拌しながら30
slのエーテルに溶かした塩化チオニル1.725g 
(11,90關o1/1.2当量)をゆっくり10分間
かけて加えた。反応液は白→黄→赤と変化し沈殿が出た
。−10’Cのまま30分撹拌した後食塩水を入れ、ジ
クロルメタン(100ml×3回)で抽出水(501m
l)食塩水(50sl)で洗い、硫酸ソーダで脱水後、
溶媒留去して黄土色の結晶2.283g(97,1%)
を得る。これをベンゼン/ヘキサンより再結晶して淡黄
色針状晶のアセトアミド誘導体1.780g (78,
4%)を得る。
m, p, 108-109°C Elemental analysis value C, Hl, 7NO8 Calculated value CC8,27%, 87.28%, C5,9
5% actual value C68, 27%, 87.38%, N 5.
73% of the above oxime 2.330 g (9,915 mm
ol) in 70 ml of dry ether and cooled to -10°C with aqueous brine. While stirring this,
1.725 g of thionyl chloride dissolved in ether of sl
(11,90 o 1/1.2 equivalents) was slowly added over 10 minutes. The reaction solution changed from white to yellow to red and a precipitate appeared. After stirring for 30 minutes at -10'C, add brine, add dichloromethane (100ml x 3 times) and extract water (501ml).
l) After washing with saline solution (50 sl) and dehydrating with sodium sulfate,
After evaporation of the solvent, 2.283 g (97.1%) of ocher crystals were obtained.
get. This was recrystallized from benzene/hexane to obtain 1.780 g of acetamide derivative (78,
4%).

m、 p、131−132° C 元素分析値 C工、H工、NO3 計算値 CG6.38%、H7,28%、  N 5.
95 %実−1値 0 8G、27%、 H7,31%
、N 5.71%上記アセトアミド1.730g (7
,3E3關of)を60m1のクライゼンアルカリ(8
8gの苛性カリを133m1の水に溶かし、メタノール
で250m1に稀釈したもの、6.29mol/I )
に溶かして1時間還流した。ジクロルメタン1001を
加え塩酸でpH>7にしてからジクロルメタン(100
m+x3)で抽出して水(50+sl)で洗い硫酸ソー
ダで脱水。溶媒留去して褐色の結晶を1.318g(9
2,6%)得た。ベンゼン/ヘキサンより再結晶して褐
色の針状晶、4,4−ジメチル−6−アミノ−チオクロ
マンを得る。
m, p, 131-132° C Elemental analysis values C engineering, H engineering, NO3 Calculated values CG6.38%, H7,28%, N 5.
95% Actual -1 value 0 8G, 27%, H7, 31%
, N 5.71% 1.730 g of the above acetamide (7
, 3E3 of) to 60 ml of Claisen alkali (8
8g of caustic potash dissolved in 133ml of water and diluted to 250ml with methanol, 6.29mol/I)
The mixture was dissolved in water and refluxed for 1 hour. Add dichloromethane 1001 and adjust the pH to >7 with hydrochloric acid, then dichloromethane (100
Extract with m+x3), wash with water (50+sl), and dehydrate with sodium sulfate. The solvent was distilled off to obtain 1.318 g (9
2.6%) was obtained. Recrystallization from benzene/hexane gives brown needle-like crystals of 4,4-dimethyl-6-amino-thiochroman.

m、p、61.5° C 計算値 CC8,37%、C7,82%、N 7.25
 %実測値 CC8,13%、87.91%、N 7.
00%実施例3で得たメチルエステル150■g(0,
423龍01)を5111のエタノールに溶かし、2N
苛性ソーダ3■1を加えて室温下−夜攪拌。反応液にI
N塩酸を加えてpH<7にしてから酢酸エチルで抽出。
m, p, 61.5° C calculated value CC8, 37%, C7, 82%, N 7.25
% Actual value CC8, 13%, 87.91%, N 7.
00% 150 g of methyl ester obtained in Example 3 (0,
Dissolve 423 Dragon 01) in 5111 ethanol and add 2N
Add 3.1 parts of caustic soda and stir at room temperature overnight. I in the reaction solution
Add N-hydrochloric acid to bring the pH to <7, then extract with ethyl acetate.

有機層を水、飽和食塩水で洗い、硫酸マグネシウムで脱
水。溶媒を留去して標記化合物を淡茶色の結晶として得
る。145mg(100%)。
The organic layer was washed with water and saturated saline, and dehydrated with magnesium sulfate. The solvent is distilled off to obtain the title compound as light brown crystals. 145 mg (100%).

酢酸エチル/ヘキサンより再結晶して淡黄色針状晶を6
8.8+++g(47,7%)を得た。
Recrystallized from ethyl acetate/hexane to give 6 pale yellow needles.
8.8+++g (47.7%) was obtained.

m、 p、214〜215° C 元素分析値 C工。八、N03S 計算値 CGG、85%、H5,[i1%、N 4.1
0%実測値 C611i、83%、H5,85%、N3
.8H%NMR(100MHz、CDCl  )δ1.
37s (8H)、δ1.97m(2H)、63.05
m (2H) 、δ7.OOd (IH,J=4.8H
z)、δ7.38dd (IH,J=4゜8 Hz +
  J = 2 Hz ) 、δ7.78d (IH,
J”2H2)、67.96 (2H,J=4..8Hz
)、δ8.12d (2H,J=4.8Hz)IR(K
Br)1670 (アミド)1B40.1522.12
83  am−1 ル1蓬U祐L(L火 下記参考例3により得られた4、4−ジメチルクロマン
−6−カルボン酸208mg (1mmol)をベンゼ
ン7+1に溶かし、塩化チオニル6+al (大過剰)
を加えて、6時間還流する。ベンゼン及び塩化チオニル
を留去し、残渣にベンゼン8m1zピリジ71m1を加
えた後、4−アミ7安息香酸メチル(1,06關o1)
を加えて、3.5日室温下に撹拌後、4−ジメチルアミ
ノピリジンを少量加え、21時間室温下に撹拌し、更に
9時間還流。反応液を酢酸エチル30m1で希釈後、有
機層を水、2N−塩酸、水、IN−炭酸ソーダ、水、飽
和食塩水の順で洗う。硫酸マグネシウムで脱水後濃縮す
ると、粗結晶213n+g (0,570no++ol
)を得る。
m, p, 214-215°C Elemental analysis value C engineering. 8. N03S Calculated value CGG, 85%, H5, [i1%, N 4.1
0% actual value C611i, 83%, H5, 85%, N3
.. 8H% NMR (100MHz, CDCl) δ1.
37s (8H), δ1.97m (2H), 63.05
m (2H), δ7. OOd (IH, J=4.8H
z), δ7.38dd (IH, J=4°8 Hz +
J = 2 Hz), δ7.78d (IH,
J"2H2), 67.96 (2H, J=4..8Hz
), δ8.12d (2H, J=4.8Hz) IR(K
Br) 1670 (amide) 1B40.1522.12
83 am-1 RU 1 Hyo U Yu L (L Tue) 208 mg (1 mmol) of 4,4-dimethylchroman-6-carboxylic acid obtained in Reference Example 3 below was dissolved in benzene 7+1, and thionyl chloride 6+al (large excess)
and reflux for 6 hours. After distilling off benzene and thionyl chloride and adding 8ml of benzene and 71ml of pyridine to the residue, methyl 4-ami7benzoate (1,06ml) was added.
After stirring at room temperature for 3.5 days, a small amount of 4-dimethylaminopyridine was added, stirring at room temperature for 21 hours, and refluxing for further 9 hours. After diluting the reaction solution with 30 ml of ethyl acetate, the organic layer was washed in this order with water, 2N hydrochloric acid, water, IN-soda carbonate, water, and saturated brine. After dehydration with magnesium sulfate and concentration, 213n+g of crude crystals (0,570no++ol
).

粗収率 66%。再結晶(ベンゼン−ヘキサン)後、標
記化合物187mgの白色結晶を得る。
Crude yield 66%. After recrystallization (benzene-hexane), 187 mg of the title compound are obtained as white crystals.

m、 p、175°C NMR(CDCI  ) δ1.40 (s、 8. C(CH3)2) 、δ1
.91 (t、 J=8Hz、 2、CH2C(CH3
す、δ3゜92 (S 、 3. C00CH,) 、
G4.40 (t、 J=2.5Hz、ILδ7.70
 (d、J=9Hz。
m, p, 175°C NMR (CDCI) δ1.40 (s, 8. C(CH3)2), δ1
.. 91 (t, J=8Hz, 2, CH2C(CH3
S, δ3゜92 (S, 3. C00CH,),
G4.40 (t, J=2.5Hz, ILδ7.70
(d, J=9Hz.

2)、δ7.79 (d、J=2.5Hz、1)、G7
. 82 (s、  1. C0NH) 、G8.05
 (d。
2), δ7.79 (d, J=2.5Hz, 1), G7
.. 82 (s, 1.C0NH), G8.05
(d.

J=9Hz、2) IR(KBr)  1710cm−11655cm−1
元素分析値 C2゜H2o04NC1Φ1/4H20計
算値 CG3.49%、 H5,4重%、N3.70%
実測値 CC3,24%、  G5.37%、  N3
.44%高度さらしこ2.84g (1,85a+mo
l)を30鵬!水に懸濁させ、これに炭酸カリ1.83
g (1゜32mmol)及び苛性カリ0.530g 
(3,83m+++o l )の混合水溶M20+sl
をゆっくりと加え、時々加温しながら激しく振り、均一
な懸濁液にしてろ過。このろ液を55〜59° Cに加
温し、4゜4−ジメチル−6−アセチルクロマン533
mg(2、81mmol)加え、1時間撹拌。反応液中
の過剰の塩素をこわし、希塩酸を加えて酸性にした後、
エーテルで抽出。有機層を水、飽和食塩水で洗い、硫酸
マグネシウムで脱水後濃縮する。  再結晶(酢エチー
ヘキサン)後、388mg(1,52m鵬o1)の白色
針状晶4. 4−ジメチル−8−クロル−クロマン−6
−カルボン酸を得る。収率58%。
J=9Hz, 2) IR (KBr) 1710cm-11655cm-1
Elemental analysis value C2゜H2o04NC1Φ1/4H20 calculated value CG3.49%, H5, 4%, N3.70%
Actual value CC3.24%, G5.37%, N3
.. 44% altitude exposed 2.84g (1,85a+mo
l) 30 peng! Suspend it in water and add 1.83 potassium carbonate to it.
g (1°32 mmol) and caustic potash 0.530 g
(3,83m+++o l ) mixed aqueous solution M20+sl
Add slowly and shake vigorously while heating occasionally to make a homogeneous suspension and filter. This filtrate was heated to 55-59°C, and 4°4-dimethyl-6-acetylchroman 533
mg (2, 81 mmol) was added and stirred for 1 hour. After destroying the excess chlorine in the reaction solution and making it acidic by adding dilute hydrochloric acid,
Extracted with ether. The organic layer is washed with water and saturated brine, dried over magnesium sulfate, and concentrated. After recrystallization (acetic acid-hexane), 388 mg (1,52 m Peng o1) of white needles4. 4-dimethyl-8-chloro-chroman-6
- Obtain carboxylic acid. Yield 58%.

m、 p、218〜219° C 元素分析値 C工、H工、03C1 計算値 C59,88%、 85.44%実測値 C5
9,75%、H5,43%実施例5で得たメチルエステ
ル40mg(0,11mmol) ヲ2alのエチルア
ルコールN苛性ソーダ2+11を加えて室温下で9時間
撹拌。
m, p, 218-219° C Elemental analysis value C engineering, H engineering, 03C1 Calculated value C59.88%, 85.44% Actual value C5
9.75%, H5.43% 40 mg (0.11 mmol) of the methyl ester obtained in Example 5, 2 al of ethyl alcohol N, caustic soda 2 + 11 were added, and the mixture was stirred at room temperature for 9 hours.

反応液にIN塩酸を°加えてpH<7にし、酢エチ10
1で3回抽出。有機層を水、飽和食塩水で洗い、硫酸マ
グネシウムで脱水後71!l縮して、標記化合物の粗結
晶39mg (0.  1 1++usol′)を得る
。粗収率100%。
Add IN hydrochloric acid to the reaction solution to adjust the pH to <7, and add 10% ethyl acetate.
Extract 3 times with 1. The organic layer was washed with water and saturated saline, and after dehydration with magnesium sulfate, 71! By condensation, 39 mg (0.1 1++ usol') of crude crystals of the title compound were obtained. Crude yield: 100%.

再結晶(酢エチーヘキサン)後、23mgの白色結晶を
得る。
After recrystallization (acetic acid ethyl hexane), 23 mg of white crystals are obtained.

m.p.275〜278° C NMR(CD  OD) δ1.41 (s,6.C (CH ))、δ1.91
 (t, J=5Hz, 2、CH2C(CH3)2)
、G4。
m. p. 275-278°C NMR (CD OD) δ1.41 (s, 6.C (CH)), δ1.91
(t, J=5Hz, 2, CH2C(CH3)2)
, G4.

36(t,J=5Hz.2,CH O)、G7。36 (t, J=5Hz.2, CH O), G7.

78 (d.J−8.5Hz.2)、67、82(cL
  J==3Hz,IL67、 92 (d,  J=
3Hz+1)、δ7.99 (d.J=8.5Hz。
78 (d.J-8.5Hz.2), 67, 82 (cL
J==3Hz, IL67, 92 (d, J=
3Hz+1), δ7.99 (d.J=8.5Hz.

IR(KBr)   1690cm−1、1880cm
−1   ′元素分析値 C19H□804NCI 計Wfa  C  63.43%、)( 5.04 %
.  N 3.89 %実測値 C  G3.2[、 
 G5.07II&、N 3.69 %1土止 実施例5で得たクロル誘導体300++g(0.802
+smol)を、329mg(5当量)の酢酸ナトリウ
ムを含む30+l酢酸に溶かし、600mgのPd−炭
を加えて、4時間半接触還元を行う。反応液を2重ろ紙
でろ過。残渣は20σ1のベンゼンで洗う。ろ過液は8
0mlの水で希釈した後、飽和重炭酸水で中和(pH8
程度)し、酢エチ100mlで3回抽出。洗液、抽出液
を合わせ、水、飽和食塩水で洗い、硫酸マグネシウムで
脱水後濃縮。標記化合物の粗結晶2 8 1mg (0
. 7 7 0+a+nol)を得る。粗収率96%、
再結晶(ベンゼン−ヘキサンから)後、231mgの白
色結晶を得る。
IR (KBr) 1690cm-1, 1880cm
-1' Elemental analysis value C19H□804NCI Total Wfa C 63.43%, ) (5.04%
.. N 3.89% Actual value C G3.2[,
G5.07II&, N 3.69%1 300++ g (0.802
+smol) is dissolved in 30+l acetic acid containing 329 mg (5 equivalents) of sodium acetate, 600 mg of Pd-charcoal is added, and catalytic reduction is carried out for 4 and a half hours. Filter the reaction solution through double filter paper. The residue is washed with 20σ1 benzene. The filtrate is 8
After diluting with 0 ml of water, neutralize with saturated bicarbonate water (pH 8).
degree) and extracted three times with 100 ml of acetic acid. Combine the washing liquid and extract, wash with water and saturated saline, dehydrate with magnesium sulfate, and concentrate. Crude crystals of the title compound 2 8 1 mg (0
.. 7 7 0+a+nol) is obtained. Crude yield 96%,
After recrystallization (from benzene-hexane) 231 mg of white crystals are obtained.

m.1)、172° C NMR(CDCI  ) δ1, 39 (sr 6+ C (CH3)2) 、
δ1.89 2 ( s 、 3. COOCB9、G
4. 26 (t, J=6Hz,2,CH20)、G
8. 84 (d. J=8Hz.L H−8) 、6
7、53 (dd.J=8 H z 、J = 3 H
 z +  1 + H − 7 ) 、δ7.72(
d.J:=8.5Hz,2)、67、90 (d。
m. 1), 172° C NMR (CDCI) δ1, 39 (sr 6+ C (CH3)2),
δ1.89 2 (s, 3.COOCB9,G
4. 26 (t, J=6Hz, 2, CH20), G
8. 84 (d. J=8Hz.L H-8), 6
7, 53 (dd. J = 8 Hz, J = 3 H
z + 1 + H − 7), δ7.72(
d. J:=8.5Hz, 2), 67, 90 (d.

J=3Hz+  L H−5)、δ7.91 (sr 
 LCONH)、δ8.05 (d.J=8.5Hz。
J=3Hz+L H-5), δ7.91 (sr
LCONH), δ8.05 (d.J=8.5Hz.

IR(KBr)   1695cm−、’、1 6 7
 0cm−1元素分析値 CHON・I/8HO 計算値 C70,31%、 HG、27%、N 4.1
0%実測値 C70,30%、HEi、27%、N 3
.89%例7で得たメチルエステル180mg(0,5
32mmo l )を4mlのエチルアルコールに溶か
し、2N苛性ソーダ2111を加えて、室温下で21時
間撹拌。
IR (KBr) 1695cm-,', 1 6 7
0cm-1 elemental analysis value CHON・I/8HO calculated value C70, 31%, HG, 27%, N 4.1
0% actual value C70, 30%, HEi, 27%, N 3
.. 89% 180 mg of methyl ester obtained in Example 7 (0,5
32 mmol) was dissolved in 4 ml of ethyl alcohol, 2N caustic soda 2111 was added, and the mixture was stirred at room temperature for 21 hours.

実施例6と同様の後処理をして、標記化合物の粗結晶I
 Ei 7mg (0,513imol)を得る。粗服
率96%、再結晶(酢酸エチル−ヘキサンから)して1
12mgの白色結晶を得る。
After the same post-treatment as in Example 6, crude crystals of the title compound I
7 mg (0,513 imol) of Ei is obtained. Crude yield 96%, recrystallized (from ethyl acetate-hexane) to 1
12 mg of white crystals are obtained.

m、1)、243〜245” C NMR(CD  OD) 61、40 (s、 6. C(C馬)2)、δ1.8
7 (t、 J=5Hz、 2、CHfJ(CG3) 
p、64゜26(t、J=5H2,2,CH20)、G
8゜82 (d、J=8Hz、1.8−8)、δ7.6
8 (dd、J=8Hz、J=3Hz、1.8−7)、
δ7.80 (d、J=8Hz、2)、δ7.97 (
d、  J”3Hz、  1.8−5)、68.00(
d、J=8Hz、2) IR(KBr)  1680cm−1,1655cm−
1元素分析値 CHON 計算値 (:  70.14%、 85.89%、N 
4.31%実測値 C1li9.99%、H5,88%
、N4.50%参考例4で得られた1、1−ジオキソ−
4,4−ジメチルチオクロマンカルボン酸994.0m
gに、少量の塩化チオニル、DMF  0.8ccを水
浴上で撹拌しながら加え、1時間反応させた。TLC(
1%酢酸エチル/ヘキザン)にて、反応が終了したこと
を確認し、室温、減圧下、塩化チオニルを留去し、更に
ベンゼンを加え、共沸によりできる限り塩化チオニルを
除去した。
m, 1), 243-245" C NMR (CD OD) 61, 40 (s, 6. C (C horse) 2), δ1.8
7 (t, J=5Hz, 2, CHfJ(CG3)
p, 64°26 (t, J=5H2,2,CH20), G
8°82 (d, J=8Hz, 1.8-8), δ7.6
8 (dd, J=8Hz, J=3Hz, 1.8-7),
δ7.80 (d, J=8Hz, 2), δ7.97 (
d, J”3Hz, 1.8-5), 68.00(
d, J=8Hz, 2) IR (KBr) 1680cm-1,1655cm-
1 element analysis value CHON calculated value (: 70.14%, 85.89%, N
4.31% actual value C1li9.99%, H5,88%
, N4.50% 1,1-dioxo- obtained in Reference Example 4
4,4-dimethylthiochromancarboxylic acid 994.0m
A small amount of thionyl chloride and 0.8 cc of DMF were added to g while stirring on a water bath, and the mixture was reacted for 1 hour. TLC(
After confirming the completion of the reaction using 1% ethyl acetate/hexane, thionyl chloride was distilled off at room temperature under reduced pressure, and benzene was added to remove as much thionyl chloride as possible by azeotropy.

これに、p−アミノ安息香酸メチル891.E3mg(
1,2当量)をベンゼン3Qccに溶解したものを水浴
上で加え、撹拌しながらピリジン0.3cc(1当量)
、4−(N、N−ジメチルアミノ)ピリジン50mgを
加え、1時間反応させ、TLC(ジクロルメタン)にて
反応の終了を確認した後、反応液にジクロルメタンを加
え、沈殿を溶解し、水、飽和炭酸水素ナトリウム、2N
塩酸にて洗い、硫酸ソーダで脱水。溶媒を留去し、白色
の粉末1゜173g (収率77.5%)を得た。これ
を酢エチ/ヘキサンから再結晶して、標記化合物を白色
の針状晶として251.4mg(m、1)、230−2
31° C)を得た。
To this, methyl p-aminobenzoate 891. E3mg (
Add 0.3cc (1 equivalent) of pyridine dissolved in 3Qcc of benzene on a water bath while stirring.
, 50 mg of 4-(N,N-dimethylamino)pyridine was added and reacted for 1 hour. After confirming the completion of the reaction by TLC (dichloromethane), dichloromethane was added to the reaction solution to dissolve the precipitate, and water was added to the saturated solution. Sodium bicarbonate, 2N
Wash with hydrochloric acid and dehydrate with sodium sulfate. The solvent was distilled off to obtain 1.173 g of white powder (yield 77.5%). This was recrystallized from ethyl acetate/hexane to give the title compound as white needle crystals, 251.4 mg (m, 1), 230-2
31°C) was obtained.

NMR(CDC1・DMSO) δ1.17 (s、 8H,C(CH3)2)、G2゜
CH25)、G3.55 (s、 3H,C00CH3
)、δ7.8 (m、 7 H+ A r −H) 、
δ9.64(s、IH,NH) 元素分析値 計算値 CG2.00%、H5,4H%、N3.82%
実測値 (:  G1.7H%、85.38 %、  
N 3.34 %同様にして、原料として、スルホン化
合物の代わりに参考例4でえられたスルホキシド化合物
を用いて対応するスルホキシドである目的化合物が得ら
れた。
NMR (CDC1/DMSO) δ1.17 (s, 8H, C(CH3)2), G2°CH25), G3.55 (s, 3H, C00CH3
), δ7.8 (m, 7 H+ A r −H),
δ9.64 (s, IH, NH) Elemental analysis value calculation value CG2.00%, H5,4H%, N3.82%
Actual value (: G1.7H%, 85.38%,
N 3.34% In the same manner, using the sulfoxide compound obtained in Reference Example 4 instead of the sulfone compound as a raw material, the corresponding sulfoxide target compound was obtained.

高度晒粉13.50gを温水53ccに懸濁させ、炭酸
カリ12.4Etg1苛性カリ3.56gを水2f3c
cに溶解したものをよく混ぜながら、少しずつ加え、K
OCI溶液(g当量)を調整した。4゜4−ジメチル−
6−アセチル−チオクロマン3゜00gにKOCI溶液
を水浴上撹拌しながら加え、そのまま80分間反応させ
、室温にて更に−・晩反応させた。TLCにて反応がほ
ぼ終了したことを確認した後、酸性亜硫酸ソーダ3.7
g/水14ccを加え、2N塩酸にて中和し、酢エチで
抽出した。有機層を2N重炭酸ソーダで抽出した。これ
を2N塩酸にて中和し、酢エチ抽出。有機層を硫酸ソー
ダで脱水し、溶媒を留去して、スルホン化合物を主とす
る白色の粉末3.03g(収率87゜5%)(m、  
p、193−195’ C)を得た。
Suspend 13.50 g of highly bleached powder in 53 cc of warm water, 12.4 Etg of potassium carbonate, 3.56 g of caustic potassium and 2 f3 c of water.
Add the solution dissolved in C little by little while mixing well, and add K
An OCI solution (g equivalent) was prepared. 4゜4-dimethyl-
The KOCI solution was added to 3.00 g of 6-acetyl-thiochroman while stirring on a water bath, reacted for 80 minutes, and further reacted overnight at room temperature. After confirming that the reaction was almost completed by TLC, add 3.7 ml of acidic sodium sulfite.
g/14 cc of water was added, neutralized with 2N hydrochloric acid, and extracted with ethyl acetate. The organic layer was extracted with 2N sodium bicarbonate. This was neutralized with 2N hydrochloric acid and extracted with acetic acid. The organic layer was dehydrated with sodium sulfate and the solvent was distilled off to obtain 3.03 g (yield 87.5%) of a white powder mainly composed of sulfone compounds (m,
p, 193-195'C) was obtained.

MS:M”=254 NMR(CDCI  ・DMSO) δL 47 (s、 8H,C(CH3)2) 、62
゜4 (m、2H,CCHC)、G3. 5 (m、 
 2H,CH8)、G8. O(m、  3H,Ar 
−H)なお、条件により、対応するスルホキサイドが主
として得られた。
MS:M”=254 NMR (CDCI DMSO) δL 47 (s, 8H, C(CH3)2), 62
゜4 (m, 2H, CCHC), G3. 5 (m,
2H, CH8), G8. O(m, 3H, Ar
-H) Depending on the conditions, the corresponding sulfoxide was mainly obtained.

実施例−」」一 実施例9で得たエステル111.3mgにメタノール4
cc、IQ%苛性ソーダlccを加え、室温で20時間
撹拌し、TLC(ジクロルメタン)にて原料エステルの
消失を確認した後、反応液に、飽和炭酸水素ナトリウム
水溶液を加え、ジクロルメタンで洗う。2N塩酸にて中
和し、酢エチで抽出、硫酸ソーダで脱水し、溶媒を留去
し、白色粉末112.7mg(収率100%)を得た。
Example - 111.3 mg of the ester obtained in Example 9 was added with 4 methanol.
cc, IQ% caustic soda lcc is added, and the mixture is stirred at room temperature for 20 hours. After confirming the disappearance of the raw material ester by TLC (dichloromethane), a saturated aqueous sodium hydrogen carbonate solution is added to the reaction solution, and the mixture is washed with dichloromethane. The mixture was neutralized with 2N hydrochloric acid, extracted with ethyl acetate, dehydrated with sodium sulfate, and the solvent was distilled off to obtain 112.7 mg of white powder (yield: 100%).

これを酢エチ/ヘキサンから再結晶し、白色針状晶61
.8mgを得た。(収率54.8%) m、 p、293−294°C NMR(CI)C13・DMS O) δ1.5 (s、6H,C(CH)  L δ2.2(
m、2H,CCHCLδ3− 5 (m+  28IC
HlS)、G8 (m、7H+  Ar  H) 、G
9゜2(s、IH) 実施伝−上上 アゾベンゼンカルボン −導体CH3C
o2H 参考例1で得た6−アミノ4,4−ジメチルクロマン1
10mg (0,62smol)と94mgのp−ニト
ロソ安息香酸メチル(0,62mmol)とを酢酸5m
lに溶かし、暗所にて室温下−晩撹拌する。
This was recrystallized from ethyl acetate/hexane and white needle crystals 61
.. 8 mg was obtained. (Yield 54.8%) m, p, 293-294°C NMR(CI)C13・DMSO) δ1.5 (s, 6H, C(CH) L δ2.2(
m, 2H, CCHCLδ3- 5 (m+ 28IC
HlS), G8 (m, 7H+ Ar H), G
9゜2 (s, IH) Practical History - Part 1 Azobenzenecarbon - Conductor CH3C
o2H 6-amino 4,4-dimethylchroman 1 obtained in Reference Example 1
10 mg (0.62 smol) and 94 mg of methyl p-nitrosobenzoate (0.62 mmol) were added to 5 m of acetic acid.
1 and stirred overnight at room temperature in the dark.

反応液を水にあけ、エーテルで抽出、有機層を水、18
重炭酸ソーダで3回、水、飽和食塩水で順次洗い硫酸マ
グネシウムで脱水、溶媒留去する。シリカゲルカラムク
ロマトグラフィーにより精製して、アゾ体メチルエステ
ル124mg(収率64゜4%)を得る。ヘキサンから
再結晶して橙色リン片品。m、1)、142−143°
C NMR(100M Hz t CD CI3)δ1.4
3s (6H)、δ1.90t (2H,J=6Hz)
 、63.98s (3H)、64.29℃(2H1J
=6H2)、δB、 90d (LH。
Pour the reaction solution into water, extract with ether, and add the organic layer to water for 18 hours.
Wash three times with sodium bicarbonate, water and saturated brine, dehydrate over magnesium sulfate, and evaporate the solvent. The product was purified by silica gel column chromatography to obtain 124 mg of azo methyl ester (yield: 64.4%). Recrystallized from hexane to produce orange phosphorus flakes. m, 1), 142-143°
C NMR (100MHz t CD CI3) δ1.4
3s (6H), δ1.90t (2H, J=6Hz)
, 63.98s (3H), 64.29℃ (2H1J
=6H2), δB, 90d (LH.

J=9Hz)、δ7.72dd (IH,J=2゜9H
2)、δ7.88d (2H,J=8.5Hz)、δ7
.95d (IH,J=2Hz) 、δ8.15d (
2H,J=8.5Hz) 元素分析値 C19H2゜N2O3 計算値 C70,35%、H8,22%、N 8.64
%実測値 C70,23%、88.17 %、  N 
8.77 %上記のメチルエステル90mg(0,29
mmol)を3mlエタノールに懸濁させる。Ar置換
下、2N苛性ソーダ21+11を加えて、暗所・室温に
て一晩撹拌する。反応液にIN塩酸を加えてpH<7に
し、析出物を酢エチで抽出する。有機層をpH→7にな
るまで水で洗い、硫酸マグネシウムで脱水。溶媒留去し
て、アゾカルボン酸75mg (収”l187゜3%)
を得る。酢酸エチルから再結晶して橙色の針杖晶を得た
J=9Hz), δ7.72dd (IH, J=2゜9H
2), δ7.88d (2H, J=8.5Hz), δ7
.. 95d (IH, J=2Hz), δ8.15d (
2H, J=8.5Hz) Elemental analysis value C19H2゜N2O3 Calculated value C70, 35%, H8, 22%, N 8.64
% Actual value C70, 23%, 88.17%, N
8.77% 90 mg of the above methyl ester (0,29
mmol) in 3 ml ethanol. Under Ar substitution, 2N caustic soda 21+11 was added, and the mixture was stirred overnight at room temperature in the dark. IN hydrochloric acid was added to the reaction solution to adjust the pH to <7, and the precipitate was extracted with ethyl acetate. The organic layer was washed with water until the pH became 7, and then dehydrated with magnesium sulfate. The solvent was distilled off to give 75 mg of azocarboxylic acid (yield: 187°3%).
get. Recrystallization from ethyl acetate gave orange needle crystals.

m、p、285−286°CO NMR(100MHz、CD  OD)δ1.43s 
(6H)、δ1.90t (2H,J= 5 Hz )
 、δ4.29t (2H,、I”5Hz)、δ6.8
8d (IH,J=9Hz)、67.69dd (IH
,J=2.9Hz)、δ7.88d(2H,J−8,5
Hz)、δ7.96d (IH。
m, p, 285-286°CO NMR (100MHz, CD OD) δ1.43s
(6H), δ1.90t (2H, J= 5 Hz)
, δ4.29t (2H,, I"5Hz), δ6.8
8d (IH, J=9Hz), 67.69dd (IH
, J=2.9Hz), δ7.88d(2H, J-8,5
Hz), δ7.96d (IH.

J=2Hz)、δ8.13d (2H,J=8.5Hz
) 元素分析(ilIC18H18N203計算値 CG9
.EiG%、 85.85 %、N 9.03 %実測
値 CG9.93%、85.92%、N 9.20%同
様にして、対応するX=Sのアゾカルボン酸メチルエス
テルm、 p、182.5−163.5゜C1及び対応
するアゾカルボン酸m、 1)、 27B。
J=2Hz), δ8.13d (2H, J=8.5Hz
) Elemental analysis (ilIC18H18N203 calculated value CG9
.. EiG%, 85.85%, N 9.03% Actual value CG 9.93%, 85.92%, N 9.20% Similarly, the corresponding azocarboxylic acid methyl ester of X=S m, p, 182. 5-163.5°C1 and the corresponding azocarboxylic acid m, 1), 27B.

5−278° Cを合成した。5-278°C was synthesized.

天動J1−Lz カルコンカルボン 9゛−ケトン体1
15mg (0,52mmol)とテレフタルアルデヒ
ド m+so I )とを、エタノール5脂1に溶かし、2
N苛性ソーダを加えて一晩撹拌する。反応液にIN塩酸
を加えてpH<7とし、析出物を酢エチで抽出する。有
機層をpH持7になるまで水で洗い、硫酸マグネシウム
で脱水、溶媒を留去して目的のカルコンカルボン酸15
0mg(収率78.4%)を得る。酢エチ/ヘキサンか
ら再結晶し淡黄色プリズム晶を得る。
Tendo J1-Lz Chalcone Carvone 9゛-ketone body 1
15 mg (0.52 mmol) and terephthalaldehyde m+so I) were dissolved in 5 parts ethanol, 1 part fat, and 2
Add N caustic soda and stir overnight. IN hydrochloric acid was added to the reaction solution to adjust the pH to <7, and the precipitate was extracted with ethyl acetate. The organic layer was washed with water until the pH reached 7, dehydrated with magnesium sulfate, and the solvent was distilled off to obtain the desired chalcone carboxylic acid 15.
0 mg (yield 78.4%) is obtained. Recrystallize from ethyl acetate/hexane to obtain pale yellow prism crystals.

m. p.217−218.5° CONMR ( 1
 0 0 MH z 、C D 3 0 D )δ1.
39s (E3H)、61.9−2.1m(2H)、δ
3.O−3.2m(2H)、δ7.18d (IH.J
=8Hz)、67、77dd (IH。
m. p. 217-218.5° CONMR (1
0 0 MHz, C D 30 D) δ1.
39s (E3H), 61.9-2.1m (2H), δ
3. O-3.2m (2H), δ7.18d (IH.J
=8Hz), 67, 77dd (IH.

J=2+  8Hz)、δ7.80s (2H)、δ7
J=2+8Hz), δ7.80s (2H), δ7
.

82d (2H.J=8Hz) 、δ8.06d (2
H,J=8Hz)、δB.11d (IH,J=2Hz
)。
82d (2H.J=8Hz), δ8.06d (2
H, J=8Hz), δB. 11d (IH, J=2Hz
).

同様にして対応するX=0の化合物、m. p. 22
3−225° Cを得る。
Similarly, the corresponding compound of X=0, m. p. 22
Obtain 3-225°C.

Claims (3)

【特許請求の範囲】[Claims] (1)一般式( I ) ▲数式、化学式、表等があります▼ 式中、Rは1ないし4個の炭素原子を有するアルキル基
、殊にメチル基またはエチル基、R_1はハロゲン原子
、R_2は水素原子、メチル基またはエチル基、Xは酸
素原子、硫黄原子、=SO_2、=SO、=NH、=N
−CH_3、または=N^+(CH_3)_2基、そし
てYは次式の基 −CONR_3− −NR_3CO− −COCR_3=CR_3− −CR_3=CR_3CO− −N=N− −N=N(O)− −N(O)=N− ▲数式、化学式、表等があります▼ (式中R_3は水素原子メチル基またはエチル基で互に
異なっていてもよい)を意味する、で示される安息香酸
誘導体
(1) General formula (I) ▲There are mathematical formulas, chemical formulas, tables, etc.▼ In the formula, R is an alkyl group having 1 to 4 carbon atoms, especially a methyl group or an ethyl group, R_1 is a halogen atom, and R_2 is Hydrogen atom, methyl group or ethyl group, X is oxygen atom, sulfur atom, =SO_2, =SO, =NH, =N
-CH_3, or =N^+(CH_3)_2 groups, and Y is a group of the following formula -CONR_3- -NR_3CO- -COCR_3=CR_3- -CR_3=CR_3CO- -N=N- -N=N(O)- -N(O)=N- ▲There are mathematical formulas, chemical formulas, tables, etc.▼ (In the formula, R_3 is a hydrogen atom, a methyl group or an ethyl group, and may be different from each other.) Benzoic acid derivative represented by
(2)(a)下記一般式( I )の基Yが−CO−CR
_3=CH−基を示す化合物を対応するアセトフェノン
誘導体とテレフタルアルデヒド酸エステル又はその誘導
体とを塩基の存在下縮合させることにより、 (b)Yが▲数式、化学式、表等があります▼基 を示す化合物を対応するY基が CR_3■CR_3基を示す化合物をエポキシ化剤を用
いて酸化することにより (c)Yが−N=N基である化合物は対応するアニリン
の誘導体を酸触媒の存在又は非存在下でパラニトロソ安
息香酸エステルと縮合することにより (d)Yが−N(O)=N−基または−N=N(O)−
基である化合物は対応するフェニルヒドロキシアミンと
パラニトロソ安息香酸又はその誘導体とを(c)項にお
けると同様に縮合させることにより (e)Yが−N=N(O)−基または−N(O)=N−
基である化合物を対応するエトロソベンゼン誘導体とパ
ラヒドロキシアミノ安息香酸又はその誘導体と(c)項
におけると同様に縮合させことにより (f)Yが−NR_3−CO−基である化合物は対応す
るアニリン誘導体をテレフタール酸の反応性誘導体(酸
ハロゲニド又はエステル等)でアシル化することにより (g)Yが−CO−NR_3−である化合物はパラアミ
ノ安息香酸又はそのエステルを対応する安息香酸の反応
性誘導体(酸ハロゲニド又はエステル等)で常法により
アシル化することにより製造し、その様にして得られた
化合物を所望により加水分解することを特徴とする一般
式( I ) ▲数式、化学式、表等があります▼ 式中、Rは1ないし4個の炭素原子を有するアルキル基
、殊にメチル基またはエチル基、R_1はハロゲン原子
、R_2は水素原子、メチル基またはエチル基、Xは酸
素原子、硫黄原子、=SO_2、=SO、=NH、=N
−CH_3、又は=N^+(CH_3)_2基、そして
Yは次式の基 −CONR_3− −NR_3CO− −COCR_3=CR_3− −CR_3=CR_3CO− −N=N− −N=N(O)− −N(O)=N− ▲数式、化学式、表等があります▼ (式中R_3は水素原子、メチル基またはエチル基で互
に異なっていてもよい)を意味する、で示される安息香
酸誘導体の製造方法
(2) (a) The group Y in the following general formula (I) is -CO-CR
By condensing a compound showing a _3=CH- group with a corresponding acetophenone derivative and a terephthalaldehyde acid ester or its derivative in the presence of a base, (b) Y represents a ▲mathematical formula, chemical formula, table, etc.▼ group. By oxidizing a compound in which the corresponding Y group is a CR_3■CR_3 group using an epoxidizing agent, (c) a compound in which Y is a -N=N group can be obtained by oxidizing the corresponding aniline derivative in the presence of an acid catalyst or By condensation with para-nitrosobenzoic acid ester in the absence of
(e) Y is -N=N(O)- group or -N(O )=N-
By condensing the compound which is a group with the corresponding etrosobenzene derivative and parahydroxyaminobenzoic acid or its derivative in the same manner as in section (c), (f) Compounds in which Y is -NR_3-CO- group correspond. By acylating an aniline derivative with a reactive derivative of terephthalic acid (such as an acid halide or ester), (g) a compound in which Y is -CO-NR_3- can be converted to para-aminobenzoic acid or its ester with the reactivity of the corresponding benzoic acid. General formula (I) characterized in that it is produced by acylation with a derivative (acid halide or ester, etc.) by a conventional method, and the compound thus obtained is hydrolyzed as desired ▲Mathematical formula, chemical formula, table etc.▼ In the formula, R is an alkyl group having 1 to 4 carbon atoms, especially a methyl group or an ethyl group, R_1 is a halogen atom, R_2 is a hydrogen atom, a methyl group or an ethyl group, X is an oxygen atom, Sulfur atom, =SO_2, =SO, =NH, =N
-CH_3, or =N^+(CH_3)_2 groups, and Y is a group of the following formula -CONR_3- -NR_3CO- -COCR_3=CR_3- -CR_3=CR_3CO- -N=N- -N=N(O)- -N(O)=N- ▲There are mathematical formulas, chemical formulas, tables, etc.▼ (In the formula, R_3 is a hydrogen atom, a methyl group, or an ethyl group and may be different from each other.) A benzoic acid derivative represented by manufacturing method
(3)一般式( I )で示される安息香酸誘導体を含有
することを特徴とする癌細胞殊に白血病細胞の分化誘導
(3) An agent for inducing differentiation of cancer cells, particularly leukemia cells, characterized by containing a benzoic acid derivative represented by general formula (I)
JP19337885A 1985-09-02 1985-09-02 Novel benzoic acid derivative Pending JPS6253981A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP19337885A JPS6253981A (en) 1985-09-02 1985-09-02 Novel benzoic acid derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP19337885A JPS6253981A (en) 1985-09-02 1985-09-02 Novel benzoic acid derivative

Publications (1)

Publication Number Publication Date
JPS6253981A true JPS6253981A (en) 1987-03-09

Family

ID=16306922

Family Applications (1)

Application Number Title Priority Date Filing Date
JP19337885A Pending JPS6253981A (en) 1985-09-02 1985-09-02 Novel benzoic acid derivative

Country Status (1)

Country Link
JP (1) JPS6253981A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0276862A (en) * 1988-07-14 1990-03-16 F Hoffmann La Roche Ag Heterocyclic compound
US5468878A (en) * 1992-10-15 1995-11-21 Idemitsu Kosan Co., Ltd. Cyclohexanedione derivatives
EP0712853A4 (en) * 1993-08-02 1996-12-11 Idemitsu Kosan Co Pyrazole derivative
WO2012030919A2 (en) 2010-09-01 2012-03-08 Thomas Jefferson University Composition and method for muscle repair and regeneration

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0276862A (en) * 1988-07-14 1990-03-16 F Hoffmann La Roche Ag Heterocyclic compound
US5468878A (en) * 1992-10-15 1995-11-21 Idemitsu Kosan Co., Ltd. Cyclohexanedione derivatives
EP0712853A4 (en) * 1993-08-02 1996-12-11 Idemitsu Kosan Co Pyrazole derivative
WO2012030919A2 (en) 2010-09-01 2012-03-08 Thomas Jefferson University Composition and method for muscle repair and regeneration
EP3721880A1 (en) 2010-09-01 2020-10-14 Thomas Jefferson University Composition and method for muscle repair and regeneration
EP4066826A1 (en) 2010-09-01 2022-10-05 Thomas Jefferson University Retinoic acid receptor gamma agonists for muscle repair and regeneration

Similar Documents

Publication Publication Date Title
US5480873A (en) Pharmaceutical compounds
KR20100132073A (en) Pai-1 inhibitor
JPH0363263A (en) N-(aryloxyalkyl)heteroaryl piperidine and n- (aryloxyalkyl) heteroaryl piperazine
KR100511626B1 (en) Method for producing quinolinone derivatives
WO1996008483A1 (en) Gallic acid derivatives, method for their preparation and their use as drugs
WO2000043016A1 (en) DICARBA-closo-DODECABORANE DERIVATIVES
JPS6253981A (en) Novel benzoic acid derivative
WO2002053523A1 (en) Tropolone derivative
EP1885695B8 (en) Indoline compounds
JPS58219169A (en) Oxazoleacetic acid derivative
EP0310126A2 (en) Derivatives of pyrocatechol-carboxylic acid, their preparation and use as active ingredients in medicines
JPH03178954A (en) Benzanilide
EP0184035B1 (en) Quinolonecarboxylic acid derivatives and process for their preparation
JPH05125052A (en) New cyclic aminophenylacetic acid derivative, its production and modifying agent for immune response containing the same as active ingredient
JPH0672866A (en) Differentiation inducing agent
JPS61268651A (en) Phenylacetic acid derivative and production thereof
EP0713865A1 (en) 2-Aminobenzenesulphonic acid and 2-aminobenzenesulphonyl chloride derivatives, their preparation and their use as synthetic intermediates
JPS61268650A (en) Naphthoquinone derivative
EP0222961A1 (en) Resorcinol ethers
CN117209472A (en) KIF18A inhibitors
Gondi et al. A Convenient Synthesis and Spectral Studies of Diamines Derivatives
EP0100257A2 (en) Aminoalkyl naphthalene derivatives, their salts, process for their preparation and the therapeutical use of these derivatives and salts
KR800001248B1 (en) Process preparing for 1-alkyl-2-(phenoxymethyl)-5-nitro-imidazoles
CN116925066A (en) Indole thiazole ketone compound and application thereof
WO2019184772A1 (en) Gibberellin-like compound, preparation method thereof, pharmaceutical composition, uses and intermediate thereof